Cargando…
Decreased RNA-binding protein IGF2BP2 downregulates NT5DC2, which suppresses cell proliferation, and induces cell cycle arrest and apoptosis in diffuse large B-cell lymphoma cells by regulating the p53 signaling pathway
Diffuse large B-cell lymphoma (DLBCL) remains difficult to treat clinically due to its highly aggressive characteristics. Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) and 5′-nucleotidase domain-containing 2 (NT5DC2) have been suggested as potential regulators in numerous types of ca...
Autores principales: | Cui, Yuying, Wen, Yu, Lv, Chao, Zhao, Dongmei, Yang, Yu, Qiu, Hongbin, Wang, Chennan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366151/ https://www.ncbi.nlm.nih.gov/pubmed/35894142 http://dx.doi.org/10.3892/mmr.2022.12802 |
Ejemplares similares
-
[Corrigendum] Decreased RNA‑binding protein IGF2BP2 downregulates NT5DC2, which suppresses cell proliferation, and induces cell cycle arrest and apoptosis in diffuse large B‑cell lymphoma cells by regulating the p53 signaling pathway
por: Cui, Yuying, et al.
Publicado: (2023) -
HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression
por: Cui, YuYing, et al.
Publicado: (2022) -
ACSM3 suppresses proliferation and induces apoptosis and cell cycle arrest in acute myeloid leukemia cells via the regulation of IGF2BP2
por: Zheng, Xin, et al.
Publicado: (2023) -
Role of IGF2BP3 in trophoblast cell invasion and migration
por: Li, W, et al.
Publicado: (2014) -
IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors
por: Müller, Simon, et al.
Publicado: (2018)